BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for March 9, 2023

March 9, 2023
Med-tech firms raising money in public or private financings, including: Biomerica, Cardio Diagnostics.
Read More

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the med-tech industry, including: Alcami, Cardio Diagnostics, Prolira.
Read More

Regulatory actions for March 9, 2023

March 9, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antev, Biogen, Biomarin, Boehringer, Eli Lilly, Inhibikase, Mesoblast, Revive, Sage.
Read More

Other news to note for March 9, 2023

March 9, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Fusion, Biocytogen, Bridgene, Carisma, Gilead, J&J, Neoleukin, Selonterra, Sesen, Surface Oncology, Takeda, Tessa.
Read More

In the clinic for March 9, 2023

March 9, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Achieve, Alterity, Biocorrx, Biothera, Cel-Sci, DBV, Fresh Tracks, JW, Molecure, Redx, Renovorx, Sernova, Sparrow, Vistagen.
Read More

Financings for March 9, 2023

March 9, 2023
Biopharmas raising money in public or private financings, including: Hemostemix, Iktos, Macrogenics, Nrx, Ring, Tiamat.
Read More

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the biopharma industry, including: Asklepios, Centogene, Evofem, Fulcrum, Homology, Lava, Nkgen, Pliant, Rome, Transgene.
Read More

Other news to note for March 8, 2023

March 8, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alimetrix, Aribio, Fujirebio, Microarrays, Miromatrix, Pharmajet, Sengine, Spectrum Solutions.
Read More

Financings for March 8, 2023

March 8, 2023
Med-tech firms raising money in public or private financings, including: Aiberry, Virax Biolabs.
Read More

Appointments and advancements for March 8, 2023

March 8, 2023
New hires and promotions in the med-tech industry, including: Accelerate Diagnostics, Aditxt, Aim Medical Robotics, Endoluxe, Heartbeam, Ivy Fertility, Maternova, Osteocentric, Swift Medical.
Read More
Previous 1 2 … 853 854 855 856 857 858 859 860 861 … 1809 1810 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 15, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

    BioWorld Science
    Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
  • Medical illustration showing layers of a blood vessel

    Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

    BioWorld Science
    More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing